Navigation Links
Siragusa Vein and Vascular Center Publishes New Article on Loving Legs at Any Age
Date:11/15/2013

Nashville, TN (PRWEB) November 15, 2013

The Siragusa Vein and Vascular Center is releasing a new article to educate the public about the simplicity and effectiveness of modern techniques used to provide relief from spider and varicose veins, no matter your age. According to the Nashville-based vein center, unsightly bulges and discolorations in the legs are not an inevitability to succumb to that comes with old age.

According to Dr. Tif Siragusa, a spider and varicose veins doctor in Nashville, spider veins and varicose veins affect men and women of all ages. “Age is only one of the factors of chronic venous insufficiency,” says Dr. Siragusa. “Other factors, such as smoking, can promote hardening of the veins and cause them to age prematurely and become ineffective.” The Center urges anyone with spider and varicose veins, as well as individuals with swollen legs and ankles, to get a venous exam. Treatments are available that are effective on patients young and old.

Dr. Siragusa and his team of vein specialists in Nashville hope that by delivering this information to the public, people of all ages will better understand the vein treatment options available to them. They encourage patients to visit their website at http://www.nashvilleveincenter.com/ to learn more about how vein disease treatment can restore the beauty of your legs at any age.

For more information, visit:
http://www.nashvilleveincenter.com/.

Varicose Vein Treatment Options

At the very least, varicose veins have an unpleasant appearance. However, they can also lead to other serious consequences such as painful, swollen legs. Over half of all Americans have some form of vein disease. Aging is probably the biggest offender in terms of risk factors for the development of varicose veins.

Is it an overgeneralization to say that we all want to look younger and healthier? Certainly, many of us do. With modern advances in technology, there are multiple treatment options available for varicose veins. Sclerotherapy, endovenous laser treatment and microphlebectomy are but a few. Now you see them…now, you don’t. In the hands of leading vein doctors, it is often just that simple.

About the Siragusa Vein and Vascular Center
The Siragusa Vein and Vascular Center is nationally recognized in venous therapies and comes highly recommended by many physicians. Dr. Tif Siragusa, Director of the center, provides a personal, individualized approach to each patient based on their history of vascular problems, physical exam findings, as well as the detailed information gained by their Duplex Ultrasound.

Siragusa Vein and Vascular Center’s minimally invasive techniques eliminate the down time associated with surgical procedures of the past. Most patients drive themselves to the office and back home after treatments, avoiding the inconvenience of disrupting the schedules of family or friends. Moms can get back to taking care of the kids that day and most people are back to work the next day. As a specialist in vein treatment and vascular surgery, Dr. Siragusa also excels in the evaluation and treatment of other conditions including Carotid Artery Stenosis, Abdominal Aortic Aneurysms, Peripheral Vascular Disease, and Deep Vein Thrombosis.

Siragusa Vein & Vascular Center
http://www.nashvilleveincenter.com/
Tel. 615-777-0744

Read the full story at http://www.prweb.com/releases/2013/11/prweb11332084.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Siragusa Vein & Vascular Launches New Campaign to Educate the Public About Sclerotherapy
2. Siragusa Vein and Vascular Launches New Health Campaign via Social Media to Educate Public About the Causes of Varicose Veins
3. Siragusa Vein and Vascular Center Launches New Health Campaign via Social Media to Educate Public about the Benefits of Ultrasound in Vein Care
4. Siragusa Vein and Vascular Publishes New Article Explaining the Differences Between Varicose Veins and Spider Veins
5. Siragusa Vein and Vascular Center Publishes New Article to Raise Awareness for Arterial Disease Prevention
6. Siragusa Vein and Vascular Launches Health Campaign on Advanced Stages of Venous Disease
7. RI Cardiovascular Institute to present 20+ abstracts at AHA annual Scientific Sessions
8. Researchers discover that the body clock may influence morning peak in adverse cardiovascular events
9. BCC Research Publishes a New Report On Global Markets for Cardiovascular Surgical Devices
10. Study finds testosterone therapy may reduce risk of cardiovascular disease
11. AGH Cardiovascular Team Explores Implantable Device Designed to Treat Congestive Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name ... New York, NY, on December 3rd, to benefit Holy Name Medical Center's programs ... event, which raised over $1 million - the largest event in the Center's ...
(Date:12/9/2016)... ... December 09, 2016 , ... The ... Cable Network (PCN) during the summer of 2016. The program was made possible ... the United States Department of Health and Human Services Administration. The broadcast, ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying record-breaking attendance at ... for its 33rd Annual Issues & Research Conference, March 2-3, 2017, at ... the conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest Healthcare Properties ... by an affiliate of Seavest, has won a prestigious national healthcare real estate ... ambulatory care center (ACC) was named “Best New Development, MOBs and Other Outpatient ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, ... Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related to ... prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 with ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Dec 9, 2016 Research and Markets has ... report to their offering. ... The global travel vaccines market to grow at ... report covers the present scenario and the growth prospects of the ... the report considers the revenue generated from the sales of various ...
(Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences ... clinical-stage biopharmaceutical company focused on the treatment of ... data from a Phase 2b trial evaluating treatment ... donepezil, compared with donepezil plus placebo in people ... the addition of intepirdine to treatment was associated ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... offer newly issued shares of common stock, $0.01 par value ... an underwritten public offering.  The final terms of the Offering ... of pricing, and there can be no assurance as to ... IRIDEX expects to use the net proceeds it will receive ...
Breaking Medicine Technology: